Literature DB >> 26135490

Hepatitis C and leptospirosis: simultaneous acute infections or recurrence of occult hepatitis C.

Rita Veiga Ferraz1, Nuno Rocha Pereira1, Cláudia Carvalho1, António Sarmento1.   

Abstract

People who inject drugs are vulnerable to several infections. To the best of our knowledge, this is the first case report of a simultaneous diagnosis of leptospirosis and acute infection or recurrence of occult hepatitis C in an HIV-infected drug user. We report a case of a 47-year-old Caucasian man with HIV infection, on antiretroviral therapy, and with a history of hepatitis C (positive anti-hepatitis C virus (HCV) and HCV RNA persistently negative) who was admitted with febrile acute hepatitis. He was a former injecting drug user, on opioid substitution therapy, who relapsed to injection drug use 3 weeks prior to admission. Work up revealed positive HCV RNA and Leptospira DNA in his urine. Four weeks later he had an undetectable HCV load, and also at 6 months of follow-up. This case highlights the presence of two concomitant infectious aetiologies of acute hepatitis in an HIV-infected drug user. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26135490      PMCID: PMC4493179          DOI: 10.1136/bcr-2015-209929

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

Review 1.  HIV and hepatitis C co-infection: acute HCV therapy.

Authors:  Christoph Boesecke; Martin Vogel
Journal:  Curr Opin HIV AIDS       Date:  2011-11       Impact factor: 4.283

2.  Rare occurrence of occult hepatitis C virus in apparently uninfected injecting drug users: a two-centre, masked, case-control study.

Authors:  P B Sugden; T N Q Pham; S Ratnarajah; B Cameron; R Bull; P A White; T I Michalak; A R Lloyd
Journal:  J Viral Hepat       Date:  2013-04-17       Impact factor: 3.728

3.  Detection of Leptospira spp. in the aqueous humor of horses with naturally acquired recurrent uveitis.

Authors:  N A Faber; M Crawford; R B LeFebvre; N C Buyukmihci; J E Madigan; N H Willits
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

Review 4.  Epidemiology and natural history of hepatitis C virus infection in injection drug users: implications for treatment.

Authors:  Mark S Sulkowski; David L Thomas
Journal:  Clin Infect Dis       Date:  2005-04-15       Impact factor: 9.079

Review 5.  Occult infection with hepatitis C virus: friend or foe?

Authors:  Peter B Sugden; Barbara Cameron; Rowena Bull; Peter A White; Andrew R Lloyd
Journal:  Immunol Cell Biol       Date:  2012-05-01       Impact factor: 5.126

6.  Treatment of acute hepatitis C virus infection in HIV+ patients: Dutch recommendations for management.

Authors:  J E Arends; F A E Lambers; J T M van der Meer; G Schreij; C Richter; K Brinkman; A I M Hoepelman
Journal:  Neth J Med       Date:  2011-01       Impact factor: 1.422

Review 7.  Leptospirosis and Weil's disease in the UK.

Authors:  A E Forbes; W J Zochowski; S W Dubrey; V Sivaprakasam
Journal:  QJM       Date:  2012-07-27

Review 8.  Acute hepatitis C in an HIV-infected patient: a case report and review of literature.

Authors:  Todd H Driver; Norah Terrault; Varun Saxena
Journal:  J Gen Intern Med       Date:  2012-11-14       Impact factor: 5.128

9.  Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.

Authors:  Chia C Wang; Elizabeth Krantz; Jared Klarquist; Meighan Krows; Lanamarie McBride; Edward P Scott; Thomas Shaw-Stiffel; Scott J Weston; Hanne Thiede; Anna Wald; Hugo R Rosen
Journal:  J Infect Dis       Date:  2007-10-31       Impact factor: 5.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.